Thyroid function in very low birthweight infants after intravenous administration of the iodinated contrast medium iopromide

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 82, Issue 3, 2000, Pages

  Dembinski, J ^a   Bartmann, P ^a   Arpe, V ^b   Kroll, M ^b   Hieronimi, G ^b  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b OLGAHOSPITAL   (Germany)

Author keywords

Contrast medium; Iodine; Iopromide; Preterm infants; Thyroid function; Thyroxine

Indexed keywords

IOPROMIDE; THYROTROPIN; THYROXINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FREE THYROXINE INDEX; HUMAN; HYPERTHYROIDISM; INFANT; PRIORITY JOURNAL; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; VERY LOW BIRTH WEIGHT;

EID: 0034065215     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.82.3.f215     Document Type: Article

References (14)

1. 1 Parravicini E, Fontana C, Paterlini G, et al. Iodine, thyroid function, and very low birth weight infants. Pediatrics 1996;98:730-4.
2. 2 Ares S, Pastor I, Quero J, Morreale de Escobar G. Thyroid complications, including overt hypothyroidism, related to the use of non-radiopaque silastic catheters for parenteral feeding in prematures requiring injection of small amounts of an iodinated contrast medium. Acta Paediatr 1995;84:579-81.
3. 3 L'Allemand D, Grüters A, Beyer P, Weber B. Iodine in contrast agents and skin desinfectants is the major cause for hypothyroidism in premature infants during intensive care. Horm Res 1987;28:42-9.
4. 4 Saule H, Preissler E, Frasch W, Adams G. Iodine burden in premature infants in roentgenologically controlled positioning of central venous silastic catheters. Monatsschrift Kinderheilkunde 1986;134:21-4.
5. 5 Wolff J, Chaikoff IL. The inhibitory action of excessive iodide upon the synthesis of diiodotyrosine and of thyroxine in the thyroid gland of the normal rat. Endocrinology 1948;43:174-9.
6. 6 Smerdely P, Lim A, Boyages SC, et al. Topical iodine-containing antiseptics and neonatal hypothyroidism in very-low-birthweight infants. Lancer 1989;16:661-4.
7. 7 Jung F, Schmitt RM, Scheller B, et al. Flow rates of roentgen contrast media of different viscosity in 4.1 Charriere coronary catheters. Z Kardiol 1996;85:537-42.
8. 8 Fisher DA. Endocrinology of fetal development. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams textbook of endocrinology. Philadelphia: WB Saunders, 1997:1273-302.
9. 9 Sherwin JR. Development of regulatory mechanisms in the thyroid: failure of iodide to suppress iodide transport activity. Proc Soc Exp Biol 1982;169:458-62.
10. 10 Castaign H, Fournet JP, Leger FA, et al. Thyroid of the newborn and postnatal iodine overload. Archives Francaises de Pediatric (Paris) 1979;36:356-68.
11. 11 Shupnik MA, Greenspan SL, Ridgway EC. Transcriptional regulation of thyrotropin subunit genes by thyrotropin-releasing hormone and dopamine in pituitary cell culture. J Biol Chem 1986;261:12675-9.
12. 12 Van den Berghe G, De Zegher F. Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 1996:24:1580-90.
13. 13 Van den Berghe G, De Zegher F, Lauwers P. Dopamine suppresses pituitary function in infants and children. Crit Care Med 1994;22:1747-53.
14. 14 Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular haemorrhage: a study of infants with birth weights less than 1500gm. J Pediatr 1978;92:529-34.